Masato Hagiwara
Scholar

Masato Hagiwara

Google Scholar ID: DepvCfQAAAAJ
Earth Species Project
Natural Language ProcessingBioacousticsEducational ApplicationsWord Segmentation
Citations & Impact
All-time
Citations
751
 
H-index
13
 
i10-index
19
 
Publications
20
 
Co-authors
8
list available
Resume (English only)
Academic Achievements
  • Paper on NatureLM-audio accepted at ICLR 2025—the first large audio-language model for animal sounds.
  • Project MOSLA paper accepted at LREC-COLING 2024 and nominated for Best Paper.
  • ISPA paper accepted at XAI-SA Workshop (ICASSP 2024).
  • Co-authored AVES and BEANS papers accepted at ICASSP 2023.
  • GitHub Typo Corpus paper accepted at LREC 2020.
  • TEASPN framework paper accepted at EMNLP 2019 (system demonstration).
  • Research featured in TechCrunch and Quartz.
  • Developed GrammarTagger (neural multilingual grammar profiler) and EXPATS (explainable automated text scoring toolkit).
Research Experience
  • Research Lead at Earth Species Project since November 2021, leading projects on non-human communication decoding.
  • Former Machine Learning Engineer/Researcher at Duolingo, led the launch of Japanese, Korean, and Chinese courses.
  • Collaborated with Mirai Translate (a Japan-based MT startup) and ACTNext (ACT’s R&D unit for educational research).
  • Co-developed an ultra fine-grained NER system with Studio Ousia, ranked #2 at TAC KBP 2019.
  • Co-authored the book 'Real-World Natural Language Processing' and is writing a book on Japanese NLP with Paul O'Leary McCann.
Background
  • Currently a Research Lead at Earth Species Project, working on decoding non-human communication using AI/ML technologies.
  • Pioneering the field of Animal Language Processing (ALP), focusing on foundation models (e.g., NatureLM-audio, AVES) and benchmarks (e.g., BEANS) for non-human animals.
  • Fluent in Chinese, Japanese, and English; currently learning Korean and Lojban.
  • Passionate about connecting language and machine learning to help people learn languages.
  • Diagnosed with stage IV lung cancer in March 2023; currently stable but with a poor prognosis; raising funds for family and medical expenses.